Salvianolic acid A

丹酚酸A

Report date: 2022/11/09 10:20:34
NME

Base Information

Drug NameSalvianolic acid A
Drug Alias Namesal A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReactive oxygen species scavengers
TargetsReactive oxygen species
Therapy Area/IndicationsDiabetic peripheral neuropathyAngina PectorisAcute Coronary Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Bencao Tianyuan Medicine Research InstituteChiatai Qingchunbao Pharmaceutical Co LtdInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyAcute Coronary Syndrome
Inactive IndicationsAngina PectorisDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A